This week in transparency news: June 30 – July 6, 2018
Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure will be bringing a weekly round-up of some of the key stories…
Topic
Clinical Trial Disclosure
Major Legal Ruling Announced in Transparency Reporting: Agencies Want to See More Data Quicker (& Data for Non-Approved Drugs Too!)
Releasing the details and results of clinical trials to the public has long been a critical ethical issue facing the pharmaceutical industry. How much information should be disclosed?…
Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma
Both the Food and Drug Administration (FDA) and independent research groups have highlighted the lack of compliance with laws (2007 FDA Amendments Act) mandating that clinical trial data…
VIDEO: Clinical Trial Disclosures; More Transparency in the Future
Ed Miseta, Editor of Clinical Leader, interviews Joe Archer, Associate Director of Trial Disclosure Services at DIA 2013. Archer discusses clinical trial disclosures, why they are important to…
Clinical Trial Disclosure: More “FDA” Needed in Past and Present Acts
Federal mandates calling for transparency of clinical trial information have been in place in the United States since 1997, but a recent move will finally give the current…
Clinical Disclosure Reporting: Are You Prepared to Meet the Expanding Requirements?
A group of House Democrats led by Congressman Edward Markey (D-Mass.) on Aug. 2, 2012 introduced the Trial and Experimental Studies Transparency (TEST) Act of 2012 (H.R. 6272),…